Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sérgio Simões

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Current Opinion in Molecular Therapeutics|November 7, 2003
Technology evaluation: LErafAON, NeoPharmJoão Nuno Moreira, Sérgio Simões
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 5, 2002
Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activityCristina Fonseca, Sérgio Simões, Rogério Gaspar
Seminars in Immunology|April 12, 2003
Notch and lymphopoiesis: a view from the microenvironmentLeonor Parreira, Hélia Neves, Sérgio Simões
Journal of Pharmaceutical Sciences|July 28, 2022
Regulatory Science Approach in Pharmaceutical Development of Follow-on Versions of Non-Biological Complex Drug ProductsDaniela M Zagalo, Sérgio Simões, João Sousa
Reviews on Recent Clinical Trials|May 14, 2008
Bcl-2-targeted antisense therapy (Oblimersen sodium): towards clinical realityJoão Nuno Moreira, Adriana Santos, Sérgio Simões
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 31, 2022
Quality by design (QbD) approach in marketing authorization procedures of Non-Biological Complex Drugs: A critical evaluationDaniela M Zagalo, João Sousa, Sérgio Simões
The Prostate|July 8, 2010
Liposomal imatinib-mitoxantrone combination: formulation development and therapeutic evaluation in an animal model of prostate cancerAna Catarina Pinto, João Nuno Moreira, Sérgio Simões
Cancer Chemotherapy and Pharmacology|December 24, 2008
Ciprofloxacin sensitizes hormone-refractory prostate cancer cell lines to doxorubicin and docetaxel treatment on a schedule-dependent mannerAna Catarina Pinto, João Nuno Moreira, Sérgio Simões
Molecular Membrane Biology|March 13, 2009
Polyethylenimine of various molecular weights as adjuvant for transfection mediated by cationic liposomesNuno Penacho, Sérgio Simões, Maria C Pedroso de Lima
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 6, 2022
Oromucosal products - Market landscape and innovative technologies: A reviewFrancisca Bastos, Ana Catarina Pinto, António Nunes, et al.
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Current Opinion in Molecular Therapeutics|November 7, 2003
Technology evaluation: LErafAON, NeoPharmJoão Nuno Moreira, Sérgio Simões
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 5, 2002
Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activityCristina Fonseca, Sérgio Simões, Rogério Gaspar
Seminars in Immunology|April 12, 2003
Notch and lymphopoiesis: a view from the microenvironmentLeonor Parreira, Hélia Neves, Sérgio Simões
Journal of Pharmaceutical Sciences|July 28, 2022
Regulatory Science Approach in Pharmaceutical Development of Follow-on Versions of Non-Biological Complex Drug ProductsDaniela M Zagalo, Sérgio Simões, João Sousa
Reviews on Recent Clinical Trials|May 14, 2008
Bcl-2-targeted antisense therapy (Oblimersen sodium): towards clinical realityJoão Nuno Moreira, Adriana Santos, Sérgio Simões
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 31, 2022
Quality by design (QbD) approach in marketing authorization procedures of Non-Biological Complex Drugs: A critical evaluationDaniela M Zagalo, João Sousa, Sérgio Simões
The Prostate|July 8, 2010
Liposomal imatinib-mitoxantrone combination: formulation development and therapeutic evaluation in an animal model of prostate cancerAna Catarina Pinto, João Nuno Moreira, Sérgio Simões
Cancer Chemotherapy and Pharmacology|December 24, 2008
Ciprofloxacin sensitizes hormone-refractory prostate cancer cell lines to doxorubicin and docetaxel treatment on a schedule-dependent mannerAna Catarina Pinto, João Nuno Moreira, Sérgio Simões
Molecular Membrane Biology|March 13, 2009
Polyethylenimine of various molecular weights as adjuvant for transfection mediated by cationic liposomesNuno Penacho, Sérgio Simões, Maria C Pedroso de Lima
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 6, 2022
Oromucosal products - Market landscape and innovative technologies: A reviewFrancisca Bastos, Ana Catarina Pinto, António Nunes, et al.
Pageof 11